Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

KLF5 CUT&Tag of HBECs at ALI with and without IL-13 stimulation

ABSTRACT: KLF5 CUT&Tag of HBECs at ALI with and without IL-13 stimulation

PROVIDER: PRJNA760775 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15720329_1.fastq.gz	Fastqsanger.gz
	SRR15720329_2.fastq.gz	Fastqsanger.gz
	SRR15720330_1.fastq.gz	Fastqsanger.gz
	SRR15720330_2.fastq.gz	Fastqsanger.gz
	SRR15720331_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

KLF5 CUT&Tag of HBECs at ALI with and without IL-13 stimulation

Project description:Using CUT&Tag, we examined KLF5-associated genomic regions in primary human bronchial epithelial cells (HBECs) cultured at air-liquid interface (ALI) with and without IL-13 stimulation.

2022-07-01 | GSE183433 | GEO

ChIP-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:We used ChIP-seq to investigate epigenomic modifications in response to IFN-a, IL-17, and IL-13 in primary human bronchial epithelial cells (HBECs).

2022-05-24 | GSE185201 | GEO

Bulk RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:We used bulk cell RNA-seq to investigate transcriptional effects of IFN-a, IL-17, and IL-13 in primary human bronchial epithelial cells (HBECs).

2022-05-24 | GSE185200 | GEO

Single cell RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:We used scRNA-seq to investigate cell type-specific transcriptional effects of IFN-a, IL-17, and IL-13 in primary human bronchial epithelial cells (HBECs).

2022-05-24 | GSE185199 | GEO

ChIP-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:ChIP-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

| PRJNA768257 | ENA

Bulk RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:Bulk RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

| PRJNA768256 | ENA

Single cell RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:Single cell RNA-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

| PRJNA768255 | ENA

scRNA-seq, bulk RNA-seq and ChIP-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

Project description:scRNA-seq, bulk RNA-seq and ChIP-seq of HBECs at ALI with and without stimulation of IFN-a, IL-17, and IL-13

| PRJNA768254 | ENA

Over-expression and knockdown of KLF5

Project description:Activation of the Ras/Erk pathway upregulates expression of the Kruppel-like Factor 5 (KLF5) transcription factor, and KLF5 is a downstream mediator of Ras oncogenic signaling. Specifically, in bladder and colon cancer cell lines KLF5 upregulates the Ras-pathway target gene cyclin D1, and facilitates entry into the S phase of the cell cycle. Ras mutations are common in lung cancer, but a role for KLF5 in lung tumorigenesis has not been defined. To this end, we manipulated KLF5 expression in four Ras-mutant human lung adenocarcinoma cell lines to find that KLF5 significantly modulates anchorage-independent growth, a mutant Ras phenotype. However, in a mouse model of human lung adenocarcinoma, K-RasG12D does not critically require Klf5 to mediate oncogenesis or induce cyclin D1 expression. Patients with lung tumors expressing high levels of KLF5 have significantly better prognosis than those with low or no KLF5 expression (opposite of mutant Ras prognosis). The latter may be explained by KLF5 transcriptional repression of the ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2), an anthracycline transporter. In agreement with this, KLF5 knockdown cells display significantly more Hoechst “side population” and resistance to doxorubicin. In summary, while KLF5 is not an obligate partner in Ras oncogenic signaling, KLF5 control of ABCG2 expression is significant to patient survival.

2010-06-23 | GSE16555 | GEO

Klf5 OE ES

Project description:Klf5 OE ES

| PRJNA1026845 | ENA